Peritoneal microcirculation

Contributions to Nephrology

Volumn 140, Issue , 2003, Pages 56-69

  Lameire, Norbert ^a   Mortier, Siska ^a   De Vriese, An ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33747331066     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000071424     Document Type: Article

References (71)

1. White R, Granger DN: The peritoneal microcirculation in peritoneal dialysis; in Gokal R, Khanna R, Krediet RT, Nolph KD (eds): Textbook of Peritoneal Dialysis. Dordrecht, Kluwer Academic, 2000, pp 107-135.
2. Gotloib L, Shostak A, Wajsbrot V: Functional structure of the peritoneum as a dialysing membrane; in Gokal R, Khanna R, Krediet RT, Nolph KD (eds): Textbook of Peritoneal Dialysis. Dordrecht, Kluwer Academic, 2000, pp 37-106.
3. Rubin J, Clawson M, Planch A, Jones Q: Measurements of peritoneal surface in man and rat. Am J Med Sci 1988;295:453-458.
4. Krediet RT, Zemel D, Imholz AL, Struijk DG: Impact of surface area and permeability on solute clearances. Perit Dial Int 1994;14(suppl 3):70-77.
5. Simionescu N: Cellular aspects of transcapillary exchange. Physiol Rev 1983;63:1536-1579.
6. Wolff JR: Ultrastructure of the terminal vascular bed as related to function; in Kaley G, Altura BM (eds): Microcirculation. Baltimore, University Park Press,1977, pp 95-130.
7. Majno G: Ultrastructure of the vascular membrane; in Handbook of Physiology. Washington, American Physiological Society, 1965, pp 2293-2375.
8. Grayson J, Mendel D: Physiology of the Splanchnic Circulation, ed 1. Baltimore, Williams & Wilkins, 1965.
9. Lanciault G, Jacobson ED: The gastrointestinal circulation. Gastroenterology 1976;71:851-873.
10. Aune S: Transperitoneal exchange. II. Peritoneal blood flow estimated by hydrogen gas clearances. Scand J Gastroenterol 1970;5:99-104.
11. Krediet RT: The physiology of peritoneal solute transport and Ultrafiltration; in Gokal R, Khanna R, Krediet RT, Nolph KD (eds): Textbook of Peritoneal Dialysis. Dordrecht, Kluwer Academic, 2000, pp 135-172.
12. Nolph KD, Popovich RP, Ghods AJ, Twardowski ZJ: Determinants of low clearances of small solutes during peritoneal dialysis. Kidney Int 1978;13:117-123.
13. Grzegorzewska AE, Antoniewicz K: An indirect estimation of effective peritoneal capillary blood flow in peritoneally dialyzed uremic patients. Perit Dial Int 1993;13(suppl 2):39-40.
14. 2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis? J Lab Clin Med 1998;132:329-340.
15. Douma CE, de WD, Struijk DG, Krediet RT: Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: A potential role for nitric oxide? Clin Nephrol 1996;45:295-302.
16. Douma CE, de WD, Struijk DG, Krediet RT: The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD. Kidney Int 1997;51:1885-1892.
17. Felt J, Richard C, McCaffrey C, Levy M: Peritoneal clearance of creatinine and insulin during dialysis in dogs: Effect of splanchnic vasodilators. Kidney Int 1979;16:459-469.
18. Renkin EM: Exchange of substances through capillary walls; in Wolstenholme GEW (ed): Ciba Foundation Symposium. Boston, Little, Brown, 1969, pp 50-66.
19. Pietrzak I, Hirszel P, Shostack A, Welch PG, Lee RE, Maher JF: Splanchnic volume, not flow rate, determines peritoneal permeability. Trans Am Soc Artif Intern Organs 1989;35:583-587.
20. White R, Korthuis R, Granger DN: The peritoneal microcirculation in peritoneal dialysis; in: Gokal R, Nolph KD (eds): The Textbook of Peritoneal Dialysis. Dordrecht, Kluwer Academic, 1994, pp 45-68.
21. Flessner MF: Small-solute transport across specific peritoneal tissue surfaces in the rat. J Am Soc Nephrol 1996;7:225-233.
22. Ronco C, Feriani M, Chiaramonte S, Brendolan A, Milan M, LaGreca G: Peritoneal blood flow: Does it matter? Perit Dial Int 1996;16(suppl 1):70-75.
23. Kim M, Lofthouse J, Flessner MF: A method to test blood flow limitation of peritoneal-blood solute transport. J Am Soc Nephrol 1997;8:471-474.
24. Kim M, Lofthouse J, Flessner MF: Blood flow limitations of solute transport across the visceral peritoneum. J Am Soc Nephrol 1997;8:1946-1950.
25. Swan KG, Reynolds DG: Adrenergic mechanisms in the canine mesenteric circulation. Am J Physiol 1971;220:1779-1785.
26. De Vriese AS, Verbeuren TJ, Vallez MO, Lameire NH, De Buyzere M, Vanhoutte PM: Off-line analysis of red blood cell velocity in renal arterioles. J Vase Res 2000;37:26-31.
27. De Vriese AS, Lameire NH: Intravital microscopy: An integrated evaluation of peritoneal function and structure. Nephrol Dial Transplant 2001;16:657-660.
28. Klyscz T, Junger M, Jung F, Zeintl H: Cap image - A new kind of computer-assisted video image analysis system for dynamic capillary microscopy. Biomed Tech (Berl) 1997;42:168-175.
29. Combet S, Ferrier ML, Van Landschoot M, Stoenoiu M, Moulin P, Miyata T, Lameire N, Devuyst O: Chronic uremia induces permeability changes, increased nitric oxide synthase expression and structural modifications in the peritoneum. J Am Soc Nephrol 2001;12:2146-2157.
30. Topley N, Liberek T, Davenport A, Li FK, Fear H, Williams JD: Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int Suppl 1996;56:17-21.
31. Jörres A, Ludat K, Sander K, Dunkel K, Lorenz F, Keck H, Frei U, Gahl GM: The peritoneal fibroblast and the control of peritoneal inflammation. Kidney Int Suppl 1996;56:22-27.
32. Visser CE, Brouwer SJ, Struijk G, Krediet RT, Beelen RH: Production of IL-lβ and TNF-α by peritoneal macrophages depends on the bacterial species and the inoculum. Adv Perit Dial 1997;13:201-204.
33. Zemel D, Imholz AL, de Waart DR, Dinkla C, Struijk DG, Krediet RT: Appearance of tumor necrosis factor-α and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int 1994;46:1422-1430.
34. Brauner A, Hylander B, Wretlind B: Tumor necrosis factor-α, interleukin-1β and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996;27:402-408.
35. Yung S, Coles GA, Davies M: IL-1β, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: Relevance to peritonitis in CAPD. Kidney Int 1996;50:1337-1343.
36. Ferrier ML, Combet S, Van Landschoot M, Stoenoiu MS, Cnops Y, Lameire N, Devuyst O: Inhibition of nitric oxide synthase reverses changes in peritoneal permeability in a rat model of acute peritonitis. Kidney Int 2001;60:2343-2350.
37. Ates K, Koc R, Nergizoglu G, Erturk S, Keven K, Sen A, Karatan O: The longitudinal effect of a single peritonitis episode on peritoneal membrane transport in CAPD patients. Perit Dial Int 2000;20:220-226.
38. Combet S, Van LM, Moulin P, Piech A, Verbavatz JM, Goffin E, Balligand JL, Lameire N, Devuyst O: Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis. J Am Soc Nephrol 1999;10:2185-2196.
39. Steinhauer HB, Schollmeyer P: Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis. Kidney Int 1986;29:584-590.
40. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI: Impact of peritoneal membrane function on long-term clinical outcome in peritoneal dialysis patients. Prit Dial Int 1999;19(suppl 2):91-94.
41. 1, expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence. Am J Nephrol 1998;18:513-519.
42. Mateijsen MA, van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, Krediet RT: Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999;19:517-525.
43. Plum J, Hermann S, Fussholler A, Schoenicke G, Donner A, Rohrborn A, Grabensee B: Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int Suppl 2001;78:42-47.
44. Combet S, Miyata T, Moulin P, Pouthier D, Goffin E, Devuyst O: Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 2000;11:717-728.
45. Margetts PJ, Kolb M, Yu L, Hoff CM, Gauldie J: A chronic inflammatory infusion model of peritoneal dialysis in rats. Perit Dial Int 2001;21(suppl 3):368-372.
46. Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J: Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 2001;107:1529-1536.
47. Yang WS, Kim BS, Lee SK, Park JS, Kim SB: Interleukin-1β stimulates the production of extra-cellular matrix in cultured human peritoneal mesothelial cells. Perit Dial Int 1999;19:211-220.
48. Norrby K: Interleukin-1α and de novo mammalian angiogenesis. Microvasc Res 1997;54:58-64.
49. Norrby K: TNF-α and de novo mammalian angiogenesis. Microvasc Res 1996;52:79-83.
50. Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, Kohno K, Kuwano M: Induction of vascular endothelial growth factor by tumor necrosis factor-α in human glioma cells. Possible roles of SP-1. J Biol Chem 1996;271:28220-28228.
51. Margetts PJ, Gyorffy S, Kolb M, Yu L, Hoff CM, Holmes CJ, Gauldie J: Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 2002;13:721-728.
52. De Vriese AS, Tilton RG, Stephan CC, Lameire NH: Vascular endothelial growth factor is essential for hyperglycemia- induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 2001;12:1734-1741.
53. Stoenoiu MS, De Vriese AS, Brouet A, Moulin P, Feron O, Lameire N, Devuyst O: Experimental diabetes induces functional and structural changes in the peritoneum. Kidney Int 2002;62:668-678.
54. Hung KY, Lin TJ, Tsai TJ, Chen WY: Impact of peritoneal membrane transport on technique failure and patient survival in a population on automated peritoneal dialysis. ASAIO J 1999;45:568-573.
55. Hung KY, Huang JW, Tsai TJ, Chen WY: Natural changes in peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients: A retrospective, seven-year cohort survey. Artif Organs 2000;24:261-264.
56. Wang T, Heimbürger O, Waniewski J, Bergström J, Lindholm B: Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998;13:1242-1249.
57. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998;9:1285-1292.
58. Devuyst O: New insights in the molecular mechanisms regulating peritoneal permeability. Nephrol Dial Transplant 2002;17:548-551.
59. Miyata T, Devuyst O, Kurokawa K, Van Ypersele DS: Toward better dialysis compatibility: Advances in the biochemistry and pathophysiology of the peritoneal membranes. Kidney Int 2002;61:375-386.
60. De Vriese AS, Mortier S, Lameire NH: What happens to the peritoneal membrane in long-term peritoneal dialysis? Perit Dial Int 2001;21(suppl 3):9-18.
61. De Vriese AS, Mortier S, Lameire NH: Neoangiogenesis in the peritoneal membrane: Does it play a role in ultrafiltration failure? Nephrol Dial Transplant 2001;16:2143-2145.
62. Krediet RT, Lindholm B, Rippe B: Pathophysiology of peritoneal membrane failure. Perit Dial Int 2000;20(suppl 4): 22-42.
63. Honda K, Nitta K, Horita S, Yumura W, Nihei H: Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 1996;72:171-176.
64. Honda K, Nitta K, Horita S, Yumura W, Nihei H, Nagai R, Ikeda K, Horiuchi S: Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultrafiltration. Nephrol Dial Transplant 1999;14:1541-1549.
65. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002;13:470-479.
66. De Vriese AS, Mortier S, Lameire NH: Glucotoxicity of the peritoneal membrane: The case for VEGF. Nephrol Dial Transplant 2001;16:2299-2302.
67. Miller FN, Nolph KD, Harris PD, Rubin J, Wiegman DL, Joshua IG, Twardowski ZJ, Ghods AJ: Microvascular and clinical effects of altered peritoneal dialysis solutions. Kidney Int 1979;15:630-639.
68. Miller FN, Nolph KD, Joshua IG, Wiegman DL, Harris PD, Andersen DB: Hyperosmolality, acetate and lactate: Dilatory factors during peritoneal dialysis. Kidney Int 1981;20:397-402.
69. White R, Barefield D, Ram S, Work J: Peritoneal dialysis solutions reverse the hemodynamic effects of nitric oxide synthesis inhibitors. Kidney Int 1995;48:1986-1993.
70. Zakaria ER, Spain DA, Harris PD, Garrison RN: In vivo quantitative description of visceral microvascular reactivity in peritoneal dialysis (abstract). Perit Dial Int 2001;21(suppl 1):21.
71. Mortier S, De Vriese AS, Van de Voorde J, Schaub TP, Passlick-Deetjen J, Lameire NH: Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration and glucose degradation products. J Am Soc Nephrol 2002;13:480-489.